Schizophrenia is a chronic and debilitating mental illness that affects about 1 percent of the population worldwide, casting a long shadow over the lives of individuals and their families. It’s a ...

A startling and worrisome new study conducted at the University of Haifa has found that people who are diagnosed with type-2 diabetes – especially women – face a 50% percent higher risk of developing ...

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) was associated with lower risks of psychiatric hospitalization and psychiatric emergency department visits in people with both ...

Schizophrenia—incoherent activity, paranoia, talking gibberish to people who aren’t there, perhaps some catatonia, right? Partially. Schizophrenia Review As of 2013 and the DSM-5, schizophrenia is no ...

Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have uncovered a strikingly similar suite of changes in gene activity in brain tissue from people ...

The faces of schizophrenia are many — defined by predominant features unique to you. Schizophrenia is a mental disorder that typically develops in adolescence or early adulthood and continues to ...

GLP-1s were associated with fewer psychiatric hospitalizations and emergency department visits, suggesting potential benefits ...

Neurodiversity could be broadly thought of as a celebration of the many ways of thinking, feeling, and interacting with the world. Neurodivergent individuals are those whose brains process information ...

Schizoaffective disorder features symptoms from both schizophrenia and bipolar disorder. They may sound similar, but schizophrenia and schizoaffective disorder represent two different conditions.